Transdermal Drug Delivery System Market Research Report by Type (Transdermal Patches and Transdermal Semisolids), by Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications, Pain Management, and Transdermal Estrogen Therapy), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Transdermal Drug Delivery System Market is expected to grow from USD 6,094.33 Million in 2020 to USD 7,669.87 Million by the end of 2025.
2. The Global Transdermal Drug Delivery System Market is expected to grow from EUR 5,343.62 Million in 2020 to EUR 6,725.08 Million by the end of 2025.
3. The Global Transdermal Drug Delivery System Market is expected to grow from GBP 4,750.49 Million in 2020 to GBP 5,978.61 Million by the end of 2025.
4. The Global Transdermal Drug Delivery System Market is expected to grow from JPY 650,419.71 Million in 2020 to JPY 818,569.69 Million by the end of 2025.
5. The Global Transdermal Drug Delivery System Market is expected to grow from AUD 8,849.78 Million in 2020 to AUD 11,137.67 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Transdermal Drug Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Transdermal Drug Delivery System Market studied across Transdermal Patches and Transdermal Semisolids. The Transdermal Patches further studied across Drug-In-Adhesive Patches, Matrix Patches, Microneedle Patches, and Reservoir Membrane Patches. The Transdermal Semisolids further studied across Gels, Ointments, and Sprays.
Based on Application, the Transdermal Drug Delivery System Market studied across Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications, Pain Management, and Transdermal Estrogen Therapy.
Based on End User, the Transdermal Drug Delivery System Market studied across Home Care Settings and Hospitals & Clinics.
Based on Geography, the Transdermal Drug Delivery System Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Transdermal Drug Delivery System Market including Boehringer Ingelheim International GmbH, Endo International, Inc., Glaxosmithkline PLC, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Lavipharm, Lead Chemicals Co., Inc., Luye Pharma Group, Mylan N.V., Novartis AG, Purdue Pharma L.P., and UCB S.A..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Drug Delivery System Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Transdermal Drug Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transdermal Drug Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transdermal Drug Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Transdermal Drug Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Transdermal Drug Delivery System Market?
6. What are the modes and strategic moves considered suitable for entering the Global Transdermal Drug Delivery System Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Transdermal Drug Delivery System Market is expected to grow from USD 6,094.33 Million in 2020 to USD 7,669.87 Million by the end of 2025.
2. The Global Transdermal Drug Delivery System Market is expected to grow from EUR 5,343.62 Million in 2020 to EUR 6,725.08 Million by the end of 2025.
3. The Global Transdermal Drug Delivery System Market is expected to grow from GBP 4,750.49 Million in 2020 to GBP 5,978.61 Million by the end of 2025.
4. The Global Transdermal Drug Delivery System Market is expected to grow from JPY 650,419.71 Million in 2020 to JPY 818,569.69 Million by the end of 2025.
5. The Global Transdermal Drug Delivery System Market is expected to grow from AUD 8,849.78 Million in 2020 to AUD 11,137.67 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Transdermal Drug Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Transdermal Drug Delivery System Market studied across Transdermal Patches and Transdermal Semisolids. The Transdermal Patches further studied across Drug-In-Adhesive Patches, Matrix Patches, Microneedle Patches, and Reservoir Membrane Patches. The Transdermal Semisolids further studied across Gels, Ointments, and Sprays.
Based on Application, the Transdermal Drug Delivery System Market studied across Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications, Pain Management, and Transdermal Estrogen Therapy.
Based on End User, the Transdermal Drug Delivery System Market studied across Home Care Settings and Hospitals & Clinics.
Based on Geography, the Transdermal Drug Delivery System Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Transdermal Drug Delivery System Market including Boehringer Ingelheim International GmbH, Endo International, Inc., Glaxosmithkline PLC, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Lavipharm, Lead Chemicals Co., Inc., Luye Pharma Group, Mylan N.V., Novartis AG, Purdue Pharma L.P., and UCB S.A..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Drug Delivery System Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Transdermal Drug Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transdermal Drug Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transdermal Drug Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Transdermal Drug Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Transdermal Drug Delivery System Market?
6. What are the modes and strategic moves considered suitable for entering the Global Transdermal Drug Delivery System Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE
6.1. Introduction
6.2. Transdermal Patches
6.2.1. Drug-In-Adhesive Patches
6.2.2. Matrix Patches
6.2.3. Microneedle Patches
6.2.4. Reservoir Membrane Patches
6.3. Transdermal Semisolids
6.3.1. Gels
6.3.2. Ointments
6.3.3. Sprays
7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION
7.1. Introduction
7.2. Cardiovascular Diseases
7.3. Central Nervous System Disorders
7.4. Hormonal Applications
7.5. Pain Management
7.6. Transdermal Estrogen Therapy
8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY END USER
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Clinics
9. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Boehringer Ingelheim International GmbH
13.2. Endo International, Inc.
13.3. Glaxosmithkline PLC
13.4. Hisamitsu Pharmaceutical Co., Inc.
13.5. Johnson & Johnson
13.6. Lavipharm
13.7. Lead Chemicals Co., Inc.
13.8. Luye Pharma Group
13.9. Mylan N.V.
13.10. Novartis AG
13.11. Purdue Pharma L.P.
13.12. UCB S.A.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE
6.1. Introduction
6.2. Transdermal Patches
6.2.1. Drug-In-Adhesive Patches
6.2.2. Matrix Patches
6.2.3. Microneedle Patches
6.2.4. Reservoir Membrane Patches
6.3. Transdermal Semisolids
6.3.1. Gels
6.3.2. Ointments
6.3.3. Sprays
7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION
7.1. Introduction
7.2. Cardiovascular Diseases
7.3. Central Nervous System Disorders
7.4. Hormonal Applications
7.5. Pain Management
7.6. Transdermal Estrogen Therapy
8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY END USER
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Clinics
9. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Boehringer Ingelheim International GmbH
13.2. Endo International, Inc.
13.3. Glaxosmithkline PLC
13.4. Hisamitsu Pharmaceutical Co., Inc.
13.5. Johnson & Johnson
13.6. Lavipharm
13.7. Lead Chemicals Co., Inc.
13.8. Luye Pharma Group
13.9. Mylan N.V.
13.10. Novartis AG
13.11. Purdue Pharma L.P.
13.12. UCB S.A.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: SCORES
TABLE 111. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 112. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 113. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RANKING
TABLE 114. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 115. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 116. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 117. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 118. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 119. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: SCORES
TABLE 111. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 112. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 113. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RANKING
TABLE 114. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 115. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 116. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 117. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 118. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 119. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 27. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025
FIGURE 29. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 35. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025
FIGURE 37. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 39. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 62. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 75. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE
FIGURE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 27. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025
FIGURE 29. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 35. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025
FIGURE 37. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 39. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 62. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 75. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE
